Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Autonomic Research
Published in: Clinical Autonomic Research 6/2010

01-12-2010 | Review Article

Catecholamines 101

Author: David S. Goldstein

Published in: Clinical Autonomic Research | Issue 6/2010

Login to get access

Abstract

This review of clinical catecholamine neurochemistry is based on the Streeten Memorial Lecture at the 19th annual meeting of the American Autonomic Society and lectures at a satellite of the 6th Congress of the International Society of Autonomic Neuroscience. Here I provide historical perspective, describe sources and meanings of plasma levels of catecholamines and their metabolites, present a model of a sympathetic noradrenergic neuron that conveys how particular aspects of sympathetic nervous function affect plasma levels of catecholamines and their metabolites, and apply the model to understand plasma neurochemical patterns associated with some drugs and disease states.
Literature
1.
Aggarwal A, Esler MD, Socratous F, Kaye DM (2001) Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. J Am Coll Cardiol 37:1246–1251PubMed
2.
Akashi YJ, Goldstein DS, Barbaro G, Ueyama T (2008) Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation 118:2754–2762PubMed
3.
Alvarenga ME, Richards JC, Lambert G, Esler MD (2006) Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med 68:8–16PubMed
4.
Axelrod FB, Goldstein DS, Holmes C, Berlin D, Kopin IJ (1996) Pattern of plasma levels of catecholamines in familial dysautonomia. Clin Auton Res 6:205–209PubMed
5.
Biaggioni I, Goldstein DS, Atkinson T, Robertson D (1990) Dopamine-beta-hydroxylase deficiency in humans. Neurology 40:370–373PubMed
6.
Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:1170–1172PubMed
7.
Blandini F, Nappi G, Fancellu R, Mangiagalli A, Samuele A, Riboldazzi G, Calandrella D, Pacchetti C, Bono G, Martignoni E (2003) Modifications of plasma and platelet levels of l-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson’s disease. J Neural Transm 110:911–922PubMed
8.
Blombery PA, Kopin IJ, Gordon EK, Markey SP, Ebert MH (1980) Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG. Arch Gen Psychiatry 37:1095–1098PubMed
9.
Bornstein S, Breidert M, Ehrhart-Bornstein M, Kloos B, Scherbaum W (1995) Plasma catecholamines in patients with Addison’s disease. Clin Endocrinol 42:215–218
10.
Bruce S, Tack C, Patel J, Pacak K, Goldstein DS (2002) Local sympathetic function in human skeletal muscle and adipose tissue assessed by microdialysis. Clin Auton Res 12:13–19PubMed
11.
Buu NT, Lussier C (1990) Origin of dopamine in the rat adrenal cortex. Am J Physiol 258:F287–F291PubMed
12.
Buu NT, Angers M, Chevalier D, Kuchel O (1984) A new method for the simultaneous analysis of free and sulfoconjugated normetanephrine, metanephrine, and 3-methoxytyramine in human urine by HPLC with electrochemical detection. J Lab Clin Med 104:425–432
13.
Chang PC, Grossman E, Kopin IJ, Goldstein DS (1994) On the existence of functional beta-adrenoceptors on vascular sympathetic nerve endings in the human forearm. J Hypertens 12:681–690PubMed
14.
Chidsey CA, Braunwald E, Morow AG, Mason DT (1963) Myocardial norepinephrine concentration in man. Effects of reserpine and congestive heart failure. N Engl J Med 269:653–658PubMed
15.
Cohn JN, Levine BT, Olivari MT (1984) Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311:819–823PubMed
16.
Dietz NM, Halliwill JR, Spielmann JM, Lawler LA, Papouchado BG, Eickhoff TJ, Joyner MJ (1997) Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol 82:1785–1793PubMed
17.
Eiden LE, Schafer MK, Weihe E, Schutz B (2004) The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflugers Arch 447:636–640PubMed
18.
Eisenhofer G, Aneman A, Friberg P, Hooper D, Fandriks L, Lonroth H, Hunyady B, Mezey E (1997) Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:3864–3871PubMed
19.
Eisenhofer G, Aneman A, Hooper D, Rundqvist B, Friberg P (1996) Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans. J Neurochem 66:1565–1573PubMed
20.
Eisenhofer G, Coughtrie MWH, Goldstein DS (1999) Dopamine sulfate: an enigma resolved. Clin Exp Pharmacol Physiol 26:S41–S53
21.
Eisenhofer G, Esler MD, Goldstein DS, Kopin IJ (1991) Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. Am J Physiol 261:E505–E515PubMed
22.
Eisenhofer G, Esler MD, Meredith IT, Dart A, Cannon RO 3rd, Quyyumi AA, Lambert G, Chin J, Jennings GL, Goldstein DS (1992) Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation 85:1775–1785PubMed
23.
Eisenhofer G, Friberg P, Goldstein DS, Esler M (1995) Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. Br J Clin Pharmacol 40:263–265PubMed
24.
Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD (1996) Cardiac sympathetic nerve function in congestive heart failure. Circulation 93:1667–1676PubMed
25.
Eisenhofer G, Goldstein DS, Kopin IJ (1989) Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal reuptake in the sympathetic nervous system in vivo. Clin Sci 76:171–182PubMed
26.
Eisenhofer G, Goldstein DS, Ropchak TG, Nguyen HQ, Keiser HR, Kopin IJ (1988) Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. J Auton Nerv Syst 24:1–14PubMed
27.
Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ (1986) Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32:2030–2033PubMed
28.
Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K (2003) Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88:2656–2666PubMed
29.
Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331–349PubMed
30.
Eisenhofer G, Rundqvist B, Aneman A, Friberg P, Dakak N, Kopin IJ, Jacobs MC, Lenders JW (1995) Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab 80:3009–3017PubMed
31.
Eisenhofer G, Walther M, Huynh T-T et al (2001) Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999–2008PubMed
32.
Eisenhofer G, Esler MD, Cox HS et al (1990) Differences in the neuronal removal of circulating epinephrine and norepinephrine. J Clin Endocrinol Metab 70:1710–1720
33.
Elchisak MA, Polinsky RJ, Ebert MH, Kopin IJ (1982) Kinetics of homovanillic acid and determination of its production rate in humans. J Neurochem 38:380–385
34.
Esler M (1982) Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci 62:247–254PubMed
35.
Esler M (1993) Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses. Pharmacol Toxicol 73:243–253PubMed
36.
Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, Lambert GW, Jennings GL, Cox HS, Seals DR (1995) Aging effects on human sympathetic neuronal function. Am J Physiol 268:R278–R285PubMed
37.
Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G (1991) Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 260:R817–R823PubMed
38.
Fahn S (1983) Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents. Adv Neurol 37:267–276PubMed
39.
Faraj BA, Camp VM, Murray DR, Kutner M, Hearn J, Nixon D (1986) Plasma l-DOPA in the diagnosis of malignant melanoma. Clin Chem 32:159–161PubMed
40.
Garland EM, Raj SR, Black BK, Harris PA, Robertson D (2007) The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 69:790–798PubMed
41.
Goldstein DS, Cannon RO, Quyyumi A, Chang P, Duncan M, Brush JE Jr, Eisenhofer G (1991) Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Syst 34:17–35PubMed
42.
Goldstein DS, Eisenhofer G, Kopin IJ (2003) Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800–811PubMed
43.
Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ (1988) Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Investig 81:213–220PubMed
44.
Goldstein DS, Eldadah B, Holmes C, Pechnik S, Moak J, Sharabi Y (2005) Neurocirculatory abnormalities in chronic orthostatic intolerance. Circulation 111:839–845PubMed
45.
Goldstein DS, Eldadah B, Sharabi Y, Axelrod FB (2008) Cardiac sympathetic hypo-innervation in familial dysautonomia. Clin Auton Res 18:115–119PubMed
46.
Goldstein DS, Feuerstein G, Izzo JL Jr, Kopin IJ, Keiser HR (1981) Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 28:467–475PubMed
47.
Goldstein DS, Hahn S-H, Holmes C, Tifft C, Harvey-White J, Milstien S, Kaufman S (1995) Monoaminergic effects of folinic acid, l-DOPA, and 5-hydroxytryptophan in dihydropteridine reductase deficiency. J Neurochem 64:2810–2813PubMed
48.
Goldstein DS, Holmes C (1997) Metabolic fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in humans. Clin Exp Hypertens 19:155–161PubMed
49.
Goldstein DS, Holmes C (2008) Neuronal source of plasma dopamine. Clin Chem 54:1864–1871PubMed
50.
Goldstein DS, Holmes C, Axelrod FB (2008) Plasma catechols in familial dysautonomia: a long-term follow-up study. Neurochem Res 33:1889–1893PubMed
51.
Goldstein DS, Holmes C, Dendi R, Li ST, Brentzel S, Vernino S (2002) Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin Auton Res 12:281–285PubMed
52.
Goldstein DS, Holmes C, Frank SM, Dendi R, Cannon RO 3rd, Sharabi Y, Esler MD, Eisenhofer G (2002) Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation 106:2358–2365PubMed
53.
Goldstein DS, Holmes C, Frank SM, Naqibuddin M, Dendi R, Snader S, Calkins H (2003) Sympathoadrenal imbalance before neurocardiogenic syncope. Am J Cardiol 91:53–58PubMed
54.
Goldstein DS, Holmes C, Imrich R (2009) Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: preliminary observations. Auton Neurosci 146(1–2):18–21 (Special Edition)
55.
Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO 3rd (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338–347PubMed
56.
Goldstein DS, Holmes C, Sewell L, Pechnik S, Kopin IJ (2010) Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine pro-drug l-DOPS. J Clin Pharmacol (in press)
57.
Goldstein DS, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G (2003) Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 60:1327–1332PubMed
58.
Goldstein DS, Kopin IJ (2008) Adrenomedullary, adrenocortical, and sympathoneural responses to stressors: a meta-analysis. Endocr Regul 42:111–119PubMed
59.
Goldstein DS, Levinson PD, Zimlichman R, Pitterman A, Stull R, Keiser HR (1985) Clonidine suppression testing in essential hypertension. Ann Intern Med 102:42–49PubMed
60.
Goldstein DS, Nurnberger J Jr, Simmons S, Gershon ES, Polinsky R, Keiser HR (1983) Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man. Life Sci 32:1057–1063PubMed
61.
Goldstein DS, Polinsky RJ, Garty M, Robertson D, Brown RT, Biaggioni I, Stull R, Kopin IJ (1989) Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 26:558–563PubMed
62.
Goldstein DS, Stull R, Eisenhofer G, Sisson JC, Weder A, Averbuch SD, Keiser HR (1986) Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma. Ann Intern Med 105:887–888PubMed
63.
Goldstein DS, Swoboda KJ, Miles JM, Coppack SW, Aneman A, Holmes C, Lamensdorf I, Eisenhofer G (1999) Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab 84:2523–2531PubMed
64.
Goldstein DS, Udelsman R, Eisenhofer G, Stull R, Keiser HR, Kopin IJ (1987) Neuronal source of plasma dihydroxyphenylalanine. J Clin Endocrinol Metab 64:856–861PubMed
65.
Goldstein DS, Zimlichman R, Stull R, Keiser HR (1986) Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans. Clin Pharmacol Ther 40:233–238PubMed
66.
Gonzalez-Trapaga JL, Nelesen RA, Dimsdale JE, Mills PJ, Kennedy B, Parmer RJ, Ziegler MG (2000) Plasma epinephrine levels in hypertension and across gender and ethnicity. Life Sci 66:2383–2392PubMed
67.
Grossman E, Goldstein DS, Hoffman A, Keiser HR (1991) Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension 17:733–741PubMed
68.
Grossman E, Rea RF, Hoffman A, Goldstein DS (1991) Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 260:R142–R147PubMed
69.
Gustafson AB, Kalkhoff RK (1982) Influence of sex and obesity on plasma catecholamine response to isometric exercise. J Clin Endocrinol Metab 55:703–708PubMed
70.
Hilz MJ, Axelrod FB, Bickel A, Stemper B, Brys M, Wendelschafer-Crabb G, Kennedy WR (2004) Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain 127:2090–2098PubMed
71.
Holmes C, Moak J, Eldadah B, Zimmerly E, Sharabi Y, Goldstein DS (2005) Dopamine contamination of infused tyramine. Clin Chem 51:1733–1735PubMed
72.
Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS (1989) Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma. Neuropharmacology 28:791–797PubMed
73.
Illi A, Sundberg S, Ojala-Karlsson P, Korhonen P, Scheinin M, Gordin A (1995) The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine. Clin Pharmacol Ther 58:221–227PubMed
74.
Ishimitsu T, Hirose S (1985) Determination of m- and p-O-methylated products of L-3,4-dihydroxyphenylalanine using high-performance liquid chromatography and electrochemical detection. Anal Biochem 150:300–308
75.
Isnard R, Pousset F, Trochu J, Chafirovskaia O, Carayon A, Golmard J, Lechat P, Thomas D, Bouhour J, Komajda M (2000) Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am J Cardiol 86:417–421PubMed
76.
Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl A, Black B, Robertson D (2000) The neuropathic postural tachycardia syndrome. N Engl J Med 343:1008–1014PubMed
77.
Jacob G, Costa F, Vincent S, Robertson D, Biaggioni I (2003) Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration. Circulation 107:2475–2479PubMed
78.
Jacob G, Gamboa A, Diedrich A, Shibao C, Robertson D, Biaggioni I (2005) Tyramine-induced vasodilation mediated by dopamine contamination: a paradox resolved. Hypertension 46:355–359PubMed
79.
Jacobsen TN, Grayburn PA, Snyder RW 2nd, Hansen J, Chavoshan B, Landau C, Lange RA, Hillis LD, Victor RG (1997) Effects of intranasal cocaine on sympathetic nerve discharge in humans. J Clin Investig 99:628–634PubMed
80.
Jordan J, Shannon JR, Black BK, Lance RH, Squillante MD, Costa F, Robertson D (1998) N(N)-nicotinic blockade as an acute human model of autonomic failure. Hypertension 31:1178–1184PubMed
81.
Kaler SG, Goldstein DS, Holmes C, Salerno JA, Gahl WA (1993) Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease. Ann Neurol 33:171–175PubMed
82.
Kaler SG, Holmes CS, Goldstein DS, Tang J, Godwin SC, Donsante A, Liew CJ, Sato S, Patronas N (2008) Neonatal diagnosis and treatment of Menkes disease. N Engl J Med 358:605–614PubMed
83.
Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108:724–728PubMed
84.
Keranen T, Gordin A, Harjola VP, Karlsson M, Korpela K, Pentikainen PJ, Rita H, Seppala L, Wikberg T (1993) The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers. Clin Neuropharmacol 16:145–156PubMed
85.
Kopin IJ (1985) Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37:333–364
86.
Kopin IJ, Rundqvist B, Friberg P, Lenders J, Goldstein DS, Eisenhofer G (1998) Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. Am J Physiol 275:R165–R173PubMed
87.
Kurz T, Richardt G, Seyfarth M, Schomig A (1996) Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue. Naunyn Schmiedeberg’s Arch Pharmacol 354:7–16
88.
Kvetnansky R, Armando I, Weise VK, Holmes C, Fukuhara K, Deka-Starosta A, Kopin IJ, Goldstein DS (1992) Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation. J Pharmacol Exp Ther 261:899–909PubMed
89.
Kvetnansky R, Goldstein DS, Weise VK, Holmes C, Szemeredi K, Bagdy G, Kopin IJ (1992) Effects of handling or immobilization on plasma levels of 3, 4-dihydroxyphenylalanine, catecholamines, and metabolites in rats. J Neurochem 58:2296–2302PubMed
90.
Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427–1434PubMed
91.
Lenders JWM, Eisenhofer G, Abeling NGGM, Berger W, Murphy DL, Konings CH, Wagemakers LMB, Kopin IJ, Karoum F, van Gennip AH, Brunner HG (1996) Specific genetic deficiencies of the A and B isozymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Investig 97:1010–1019PubMed
92.
Letellier S, Garnier JP, Spy J, Bousquet B (1997) Determination of the l-DOPA/l-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma. J Chromatogr B Biomed Appl 696:9–17
93.
Levinson PD, Goldstein DS, Munson PJ, Gill JR Jr, Keiser HR (1985) Endocrine, renal, and hemodynamic responses to graded dopamine infusions in normal men. J Clin Endocrinol Metab 60:821–826
94.
Lonart G, Sudhof TC (2000) Assembly of SNARE core complexes prior to neurotransmitter release sets the readily releasable pool of synaptic vesicles. J Biol Chem 275:27703–27707PubMed
95.
Mardh G, Sjoquist B, Anggard E (1982) Norepinephrine metabolism in man using deuterium labeling: turnover 4-hydroxy-3-methoxymandelic acid. J Neurochem 38:1582–1587
96.
Mayer AF, Schroeder C, Heusser K, Tank J, Diedrich A, Schmieder RE, Luft FC, Jordan J (2006) Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension 48:120–126PubMed
97.
Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD (1992) Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension 19:628–633PubMed
98.
Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR (2000) Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 343:1362–1368PubMed
99.
Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, Tahvanainen KU, Kuusela TA, Diedrich AM (1997) Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation 96:2509–2513PubMed
100.
Nutt JG, Woodward WR, Beckner RM, Stone CK, Berggren K, Carter JH, Gancher ST, Hammerstad JP, Gordin A (1994) Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients. Neurology 44:913–919PubMed
101.
Oliver G, Schafer EA (1895) On the physiological action of extract of the suprarenal capsules. J Physiol 17:ix–xiv
102.
Pearson J, Brandeis L, Goldstein M (1979) Tyrosine hydroxylase immunoreactivity in familial dysautonomia. Science 206:71–72PubMed
103.
Pearson J, Gallo G, Gluck M, Axelrod F (1980) Renal disease in familial dysautonomia. Kidney Int 17:102–112PubMed
104.
Pearson J, Pytel BA (1978) Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci 39:47–59PubMed
105.
Penttila J, Syvalahti E, Hinkka S, Kuusela T, Scheinin H (2001) The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers. Psychopharmacology (Berl) 154:343–349
106.
Robertson D (1999) The epidemic of orthostatic tachycardia and orthostatic intolerance. Am J Med Sci 317:75–77PubMed
107.
Robertson D, Goldberg MR, Tung CS, Hollister AS, Robertson RM (1986) Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J Clin Investig 78:576–581PubMed
108.
Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I, Luft FC, Jordan J (2002) Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation 105:347–353PubMed
109.
Scriven AJI, Dollery CT, Murphy MB, Macquin I, Brown MJ (1983) Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine. Clin Pharmacol Ther 33:710–716PubMed
110.
Seals DR, Esler MD (2000) Human ageing and the sympathoadrenal system. J Physiol 528:407–417PubMed
111.
Senard JM, Valet P, Durrieu G, Berlan M, Tran MA, Montastruc JL, Rascol A, Montastruc P (1990) Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Investig 20:613–619
112.
Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342:541–549PubMed
113.
Sharabi Y, Imrich R, Holmes C, Pechnik S, Goldstein DS (2008) Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson’s disease with orthostatic hypotension. Mov Disord 23:1725–1732PubMed
114.
Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598–605PubMed
115.
116.
Sofuoglu M, Nelson D, Babb DA, Hatsukami DK (2001) Intravenous cocaine increases plasma epinephrine and norepinephrine in humans. Pharmacol Biochem Behav 68:455–459PubMed
117.
Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr (1997) Metyrosine and pheochromocytoma. Arch Intern Med 157:901–906PubMed
118.
Sundberg S, Scheinin M, Illi A, Akkila J, Gordin A, Keranen T (1993) The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise. Br J Clin Pharmacol 36:451–456PubMed
119.
Swoboda KJ, Hyland K, Goldstein DS, Kuban KC, Arnold LA, Holmes CS, Levy HL (1999) Clinical and therapeutic observations in aromatic l-amino acid decarboxylase deficiency. Neurology 53:1205–1211PubMed
120.
Tank J, Schroeder C, Diedrich A, Szczech E, Haertter S, Sharma AM, Luft FC, Jordan J (2003) Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation 107:2949–2954PubMed
121.
Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41:233–243PubMed
122.
Thompson JM, O’Callaghan CJ, Kingwell BA, Lambert GW, Jennings GL, Esler MD (1995) Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency. J Auton Nerv Syst 55:198–206PubMed
123.
Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343:847–855PubMed
124.
Vincent HH, Man in’t Veld AJ, Boomsma F, Wenting GJ, Schalekamp MADH (1982) Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man. Br J Clin Pharmacol 13:717–721PubMed
125.
Vincent S, Bieck PR, Garland EM, Loghin C, Bymaster FP, Black BK, Gonzales C, Potter WZ, Robertson D (2004) Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation 109:3202–3207PubMed
126.
Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM (2003) Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl) 166:264–270
127.
Wallin BG, Sundlof G (1982) Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst 6:287–291PubMed
128.
Williams M, Young JB, Rosa RM, Gunn S, Epstein FH, Landsberg L (1986) Effect of protein ingestion on urinary dopamine excretion: evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man. J Clin Investig 78:1687–1693PubMed
129.
Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548PubMed
130.
Wolfovitz E, Grossman E, Folio CJ, Keiser HR, Kopin IJ, Goldstein DS (1993) Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. Clin Sci 84:549–557PubMed
131.
Yamamoto T, Polinsky RJ, Goldstein DS, Baucom CE, Kopin IJ (1996) Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure. J Lab Clin Med 128:488–491PubMed
132.
Zavadil AP, Ross RJ, Calil HM, Linnoila M, Blombery P, Jimerson DC, Kopin IJ, Potter WZ (1984) The effect of desmethylimipramine on the metabolism of norepinephrine. Life Sci 35:1061–1068PubMed
133.
Ziegler MG, Lake CR, Kopin IJ (1976) Deficient sympathetic nervous response in familial dysautonomia. N Engl J Med 294:630–633PubMed
134.
Ziegler MG, Lake CR, Kopin IJ (1977) The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 296:293–297PubMed
Metadata
Title
Catecholamines 101
Author
David S. Goldstein
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Clinical Autonomic Research / Issue 6/2010
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-010-0065-7

Other articles of this Issue 6/2010

Clinical Autonomic Research 6/2010 Go to the issue

Short Communication

Glossopharyngeal insufflation induces cardioinhibitory syncope in apnea divers

Research Article

The effect of ice water ingestion on autonomic modulation in healthy subjects

Research Article

New method to measure and improve consistency of baroreflex sensitivity values

Research Article

Sympathetic cardiovascular hyperactivity precedes brain death

Research Letter

Unexplained changes in tilt table test outcomes after moving to a new laboratory

Research Article

Strong potential for baroreflex-governed sympathetic outflow revealed during nausea